ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 44, Issue 2, 2015, Pages 126-133

  Tanaka, Junichi ^a   Irié, Tarou ^a   Yamamoto, Gou ^a   Yasuhara, Rika ^a   Isobe, Tomohide ^a   Hokazono, Chie ^a   Tachikawa, Tetsuhiko ^a   Kohno, Yohko ^a   Mishima, Kenji ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Angiopoietin like protein 4; Cancer therapy; Invasion; Lymph node metastasis; Oral squamous cell carcinoma

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ANGPTL4 PROTEIN, HUMAN; CONDITIONED MEDIUM; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL; CANCER GRADING; CELL INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; BIOPSY; CELL CULTURE TECHNIQUE; CELL MOTION; CHEMISTRY; COMPARATIVE STUDY; CONDITIONED MEDIUM; GENE SILENCING; GENETICS; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE;

ANGIOPOIETINS; BIOMARKERS, TUMOR; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MOUTH NEOPLASMS; NEOPLASM GRADING; RNA, SMALL INTERFERING;

EID: 84921435963     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12212     Document Type: Article

References (47)

1. Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011; 23: 237-46.
2. Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontology 2000; 2011: 19-37.
3. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-16.
4. Yao M, Epstein JB, Modi BJ, et al. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol 2007; 43: 213-23.
5. Casiglia J, Woo SB. A comprehensive review of oral cancer. Gen Dent 2001; 49: 72-82.
6. Takes RP. Staging of the neck in patients with head and neck squamous cell cancer: imaging techniques and biomarkers. Oral Oncol 2004; 40: 656-67.
7. Karatzanis AD, Waldfahrer F, Psychogios G, et al. Resection margins and other prognostic factors regarding surgically treated glottic carcinomas. J Surg Oncol 2010; 101: 131-6.
8. Fan S, Tang QL, Lin YJ, et al. A review of clinical and histological parameters associated with contralateral neck metastases in oral squamous cell carcinoma. Int J Oral Sci 2011; 3: 180-91.
9. Lea J, Bachar G, Sawka AM, et al. Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck 2010; 32: 184-90.
10. Okura M, Aikawa T, Sawai NY, et al. Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 2009; 45: 908-11.
11. Grandi C, Alloisio M, Moglia D, et al. Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg 1985; 8: 67-73.
12. Greenberg JS, Fowler R, Gomez J, et al. Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 2003; 97: 1464-70.
13. Sano D, Myers JN. Metastasis of squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev 2007; 26: 645-62.
14. Hayashi S, Tanaka J, Okada S, et al. Lin28a is a putative factor in regulating cancer stem cell-like properties in side population cells of oral squamous cell carcinoma. Exp Cell Res 2013; 319: 1220-8.
15. Mishima K, Inoue K, Hayashi Y. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol 2002; 38: 468-74.
16. Mishima K, Yamada E, Masui K, et al. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod Pathol 1998; 11: 886-91.
17. Bosch FX, Andl C, Abel U, et al. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int J Cancer 2005; 114: 779-90.
18. Kurtz KA, Hoffman HT, Zimmerman MB, et al. Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas. Otolaryngol Head Neck Surg 2006; 134: 142-6.
19. Kyzas PA, Stefanou D, Batistatou A, et al. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006; 30: 185-93.
20. Padua D, Zhang XH, Wang Q, et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133: 66-77.
21. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008; 18: 6-14.
22. Katoh Y, Katoh M. Comparative integromics on Angiopoietin family members. Int J Mol Med 2006; 17: 1145-9.
23. Mandard S, Zandbergen F, van Straten E, et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 2006; 281: 934-44.
24. Romeo S, Pennacchio LA, Fu Y, et al. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007; 39: 513-6.
25. Kim I, Kim HG, Kim H, et al. Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 2000; 346, 603-10.
26. Yin W, Romeo S, Chang S, et al. Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 2009; 284: 13213-22.
27. le Jan S, Amy C, Cazes A, et al. Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 2003; 162: 1521-8.
28. Galaup A, Cazes A, le Jan S, et al. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 2006; 103: 18721-6.
29. Li KQ, Li WL, Peng SY, et al. Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection. Chin Med J 2004; 117: 1364-9.
30. Ifon ET, Pang AL, Johnson W, et al. U94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3. Cancer Cell Int 2005; 5: 19.
31. Nakayama T, Hirakawa H, Shibata K, et al. Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep 2010; 24: 599-606.
32. Girroir EE, Hollingshead HE, Billin AN, et al. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 2008; 243: 236-43.
33. Zhu P, Tan MJ, Huang RL, et al. Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 2011; 19: 401-15.
34. Ito Y, Oike Y, Yasunaga K, et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 2003; 63: 6651-7.
35. Chui X, Egami H, Yamashita J, et al. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues. Br J Cancer 1996; 73: 1233-6.
36. Beck T, Weikel W, Brumm C, et al. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Gynecol Oncol 1994; 53: 220-7.
37. Mamedova LK, Robbins K, Johnson BJ, et al. Tissue expression of angiopoietin-like protein 4 in cattle. J Anim Sci 2010; 88: 124-30.
38. Zhang H, Wong CC, Wei H, et al. HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 2012; 31: 1757-70.
39. Izraely S, Sagi-Assif O, Klein A, et al. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int J Cancer 2012; 131: 1071-82.
40. Huang XF, Han J, Hu XT, et al. Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines. Oncol Rep 2012; 27: 1541-7.
41. Nakayama T, Hirakawa H, Shibata K, et al. Expression of angiopoietin-like 4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous invasion and distant metastasis. Oncol Rep 2011; 25: 929-35.
42. Huang RL, Teo Z, Chong HC, et al. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood 2011; 118: 3990-4002.
43. Cazes A, Galaup A, Chomel C, et al. Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 2006; 99: 1207-15.
44. Murata M, Yudo K, Nakamura H, et al. Hypoxia upregulates the expression of angiopoietin-like-4 in human articular chondrocytes: role of angiopoietin-like-4 in the expression of matrix metalloproteinases and cartilage degradation. J Orthop Res 2009; 27: 50-7.
45. Kim SH, Park YY, Kim SW, et al. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res 2011; 71: 7010-20.
46. Li H, Ge C, Zhao F, et al. Hypoxia-inducible factor 1 alpha-activated angiopoietin-like protein 4 contributes to tumor metastasis via vascular cell adhesion molecule-1/integrin beta1 signaling in human hepatocellular carcinoma. Hepatology 2011; 54: 910-9.
47. Yotsumoto F, Tokunaga E, Oki E, et al. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer. Mol Cancer Res 2013; 11: 506-17.